Kelechi Anyatonwu

When Does Tissue Processing Cross The Regulatory Line And Require Pre-Market Review?

FDA Launches Expedited IND Pilot Program, Begins Accepting Applications

OIG Issues Medicare Advantage Industry Segment-Specific Compliance Program Guidance, Creating Implications For Downstream Entities